ASCAT-EHA-BSH Sickle Cell Disease Conference 2022

EHA joined forces with the British Society of Haematology (BSH) & Annual Academy of Sickle Cell and Thalassaemia Conference (ASCAT) in organizing the 3rd Sickle Cell & Thalassaemia Conference (the 17th Annual Sickle Cell & Thalassaemia Conference).

Dates: October 20-22, 2022
Location: London, United Kingdom
Format: Physical only

The Annual Scientific Conference on Sickle Cell and Thalassaemia (ASCAT) focuses on promoting the latest advances in diagnosis, treatment, and emerging fields in hemoglobinopathies. It is an opportunity to interact with peers on the latest advances in clinical care, transition services, and emerging new therapies including updates for curative treatment options.

Abstract submission

Abstract submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers as an oral presentation or poster. All the accepted abstracts will also be published in the Abstract Book, as an official supplement of HemaSphere.

Please select the most appropriate topic during the abstract & case submission:

  1. Basic and translational

  2. Novel therapies, gene therapies and bone marrow transplant

  3. Artificial intelligence, deep learning and other technological advancements in hemoglobinopathies

  4. Clinical, public health and epidemiological studies

  5. Clinical, infection and nutritional deficiencies

  6. Ageing and end organ damage

  7. Health services and outcomes research including psychology

Abstract submission is closed

Date Deadline
July 1, 2022 Start abstract & case submission
September 9, 2022 Deadline abstract & case submission
September 23, 2022 Notification of allocation to authors

For any questions regarding the abstract submission process, please contact

Target audience

Consultant Hematologists, Pediatricians, Specialist Nurses, Psychologists, Scientists, Fellows and trainees in all related fields


The meeting will take place Park Plaza, Westminister, London, United Kingdom.

For more information, click here.


The registration is closed.

For more information, click here.


The program can be found here.

EHA Topics-in-Focus Hemoglobinopathies

Topics in Focus Hemoglobinopathies 02 650x365px
This meeting is part of the EHA Topics-in-Focus (TIF) program on Hemoglobinopathies, aimed at raising awareness, providing education, furthering research, and building a network of experts to improve patient care. Further information, please see our website.

EBAH accredited stamp DEF2


EBAH CME accreditation

This meeting is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with the up-to-date views on clinical policy will enable you to raise your professional level, ultimately resulting in the best treatment for your patients.